Sellas Life Sciences Group announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock. Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SLS:
- SELLAS Life Sciences Announces Pricing of $20.0 Million Underwritten Public Offering
- SELLAS Life Sciences Announces Proposed Underwritten Public Offering
- Sellas Life Sciences to hold a conference call
- Sellas Life Sciences to host KOL webinar on GPS AML program
- SELLAS Life Sciences to Host Key Opinion Leader Webinar on Galinpepimut-S Acute Myeloid Leukemia Program